Delivery Order SPE2DB22D1106-SPE2DB25FEXR6
Award Date 7/14/25
Potential Completion Date 7/15/25
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $24,682.58 to AmerisourceBergen Drug Corp for Briviact 10 mg/ml oral solution (300ml) on September 5, 2025, with a completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location...
- The Defense Logistics Agency awarded a delivery order valued at $3,047.30 to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Briviact 10 mg/mL oral solution (300 mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 20, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and operations as a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,793.15 delivery order on August 18, 2025, for Briviact 75 mg tablets (60-count units) through a firm fixed-price contract with an ultimate completion date of August 19, 2025. The award is non-set-aside and competitively awarded, with performance to take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 16, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Briviact 10 mg/ml oral solution in a 300ml quantity. This competitive, non-set-aside contract carries a ceiling value of $5,691.66 and is structured as a firm fixed price delivery order with an ultimate completion date of September 17, 2025. The performance location is...
- The Defense Logistics Agency awarded a $9,544.90 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity. This contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the vendor based on capability and pricing. The performance location is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity, with a ceiling value of $2,116.72. This competitively awarded, firm fixed-price delivery order is set to be completed by August 13, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for Briviact 10 mg/mL oral solution (300 mL) valued at $1,861.78. This firm fixed-price delivery order, awarded on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a competitively awarded contract with no set-aside designation. The order will be fulfilled at the vendor's Conshohocken location...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,002.64 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Briviact 100 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 24, 2025, with performance to occur at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Briviact 10 mg/ml oral solution in a 300 ml quantity, with a ceiling value of $1,861.78. This is a firm fixed-price delivery order with no set-aside designation, executed on a competitive basis. The contract is set to reach ultimate completion by June 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...